Natera Reports Third Quarter 2024 Financial Results
Natera, Inc. (NTRA)
Last natera, inc. earnings: 2/26 04:10 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.natera.com
Company Research
Source: Business Wire
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today reported its financial results for the third quarter ended September 30, 2024.Recent Strategic and Financial HighlightsGenerated total revenues of $439.8 million in the third quarter of 2024, compared to $268.3 million in the third quarter of 2023, a record increase of 63.9%. Product revenues grew 64.4% over the same period.Generated a gross margin of 61.8% in the third quarter of 2024, compared to a gross margin of 45.1% in the third quarter of 2023.Processed approximately 775,800 tests in the third quarter of 2024, compared to approximately 626,000 tests in the third quarter of 2023, an increase of 23.9%.Performed approximately 137,100 oncology tests in the third quarter of 2024, compared to approximately 88,800 in the third quarter of 2023, an increase of 54.4%.Achieved positive cash flow of approximately $34.5 million1 in the third quarter of 2024.Raising an
Show less
Read more
Impact Snapshot
Event Time:
NTRA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NTRA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NTRA alerts
High impacting Natera, Inc. news events
Weekly update
A roundup of the hottest topics
NTRA
News
- Natera, Inc. (NASDAQ: NTRA) had its price target raised by analysts at TD Cowen from $155.00 to $175.00. They now have a "buy" rating on the stock.MarketBeat
- Natera, Inc. (NASDAQ: NTRA) had its price target raised by analysts at Craig Hallum from $121.00 to $157.00. They now have a "buy" rating on the stock.MarketBeat
- Natera, Inc. (NASDAQ: NTRA) had its price target raised by analysts at JPMorgan Chase & Co. from $135.00 to $160.00. They now have an "overweight" rating on the stock.MarketBeat
- Global Preterm Birth Diagnostic Test Kit Market Set for Strong Growth, Projected to Reach USD 316.5 Million by 2034: Key Growth Drivers and Trends | Future Market Insights, Inc. [Yahoo! Finance]Yahoo! Finance
- Natera, Inc. (NASDAQ: NTRA) had its price target raised by analysts at Canaccord Genuity Group Inc. from $150.00 to $165.00. They now have a "buy" rating on the stock.MarketBeat
NTRA
Earnings
- 11/12/24 - Beat
NTRA
Sec Filings
- 11/13/24 - Form 4
- 11/13/24 - Form 144
- 11/12/24 - Form 4
- NTRA's page on the SEC website